PE firm puts PromptCare up for sale
By HME News Staff
Updated 12:21 PM CDT, Tue March 16, 2021
NEW PROVIDENCE, R.I. – The Halifax Group, which invested in PromptCare Companies in 2017, is now looking to sell the company, according to PE Hub.
The process is in its second rounds, with first-round bids already submitted, according to the publication.
Because PromptCare has two distinct businesses – home infusion therapy and complex respiratory therapy – there may be two separate transactions, according to PE Hub.
PromptCare has nearly tripled in size since Halifax made its investment in 2017, expanding its presence beyond the mid-Atlantic, according to the publication. Most recently, on March 3, the company announced it had acquired the assets of NBN Infusions, expanding its footprint in the Northeast.
Halifax says it is dedicated to partnering with founders and managers of lower middle-market businesses with total enterprise values generally between $50 million and $300 million.
Comments